Ethical Criteria for Human Trials of Stem-Cell-Derived Dopaminergic Neurons in Parkinson's Disease
American Journal of Bioethics Neuroscience 6 (1):52-60 (2015)
Abstract
This article has no associated abstract. (fix it)Author's Profile
DOI
10.1080/21507740.2014.990544
My notes
Similar books and articles
Refining Ethical Guidelines for Early Clinical Trials of Pluripotent Stem-Cell-Derived Therapeutics for Parkinson's Disease.Audrey R. Chapman - 2015 - American Journal of Bioethics Neuroscience 6 (1):65-66.
Uncertain translation, uncertain benefit and uncertain risk: Ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.Ronald K. F. Fung & Ian H. Kerridge - 2013 - Bioethics 27 (2):89-96.
Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease.Z. Master, M. McLeod & I. Mendez - 2007 - Journal of Medical Ethics 33 (3):169-173.
Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo & Lindsay Parham - 2010 - Journal of Law, Medicine and Ethics 38 (2):257-266.
Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo & Lindsay Parham - 2010 - Journal of Law, Medicine and Ethics 38 (2):257-266.
Translating Stem Cell Research: Challenges at the Research Frontier.David Magnus - 2010 - Journal of Law, Medicine and Ethics 38 (2):267-276.
Which patient groups should be asked to participate in first-in-human trials of stem-cell-based therapies?Kristina Hug & Göran Hermerén - 2012 - Journal of Clinical Ethics 23 (3):256-271.
Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy.Audrey R. Chapman & Courtney C. Scala - 2012 - Kennedy Institute of Ethics Journal 22 (3):243-261.
Neural transplants for parkinson’s disease: what are the issues?Roger Barker - 2006 - Poiesis and Praxis 4 (2):129-143.
Ethical Aspects of the Use of Stem Cell Derived Gametes for Reproduction.Heidi Mertes & Guido Pennings - 2010 - Health Care Analysis 18 (3):267-278.
Differentiation of pluripotent stem cells into retinal pigmented epithelium.R. H. Croze & D. O. Clegg - unknown
Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges.Insoo Hyun - 2010 - Journal of Law, Medicine and Ethics 38 (2):277-285.
Some Ethical Concerns About Human Induced Pluripotent Stem Cells.Yue Zheng - 2016 - Science and Engineering Ethics 22 (5):1277-1284.
Who should control the use of human embryonic stem cell lines: A defence of the donors' ability to control. [REVIEW]Søren Holm - 2006 - Journal of Bioethical Inquiry 3 (1-2):55-68.
Safety Issues In Cell-Based Intervention Trials.Liza Dawson, Alison S. Bateman-House, Dawn Mueller Agnew, Hilary Bok, Dan W. Brock, Aravinda Chakravarti, Mark Greene, Patricia King, Stephen J. O'Brien, David H. Sachs, Kathryn E. Schill, Andrew Siegel & Davor Solter - 2003 - Fertility and Sterility 80 (5):1077-1085.
Analytics
Added to PP
2018-06-22
Downloads
12 (#806,664)
6 months
1 (#455,463)
2018-06-22
Downloads
12 (#806,664)
6 months
1 (#455,463)
Historical graph of downloads
Author's Profile
Citations of this work
Is a ‘Last Chance’ Treatment Possible After an Irreversible Brain Intervention?Frederic Gilbert, Alexander R. Harris, Susan Dodds & Robert M. I. Kapsa - 2015 - American Journal of Bioethics Neuroscience 6 (2):W1-W2.
Consent Through Rose-Tinted Glasses: The Optimistic Bias in Parkinson's Disease Clinical Trials.Lynn A. Jansen & Eran Klein - 2015 - American Journal of Bioethics Neuroscience 6 (1):63-64.
What Lies Ahead for Neuroethics Scholarship and Education in Light of the Human Brain Projects?Karen S. Rommelfanger & L. Syd M. Johnson - 2015 - American Journal of Bioethics Neuroscience 6 (1):1-3.
Refining Ethical Guidelines for Early Clinical Trials of Pluripotent Stem-Cell-Derived Therapeutics for Parkinson's Disease.Audrey R. Chapman - 2015 - American Journal of Bioethics Neuroscience 6 (1):65-66.
Ethical Challenges of Stem-Cell Transplantation in Parkinson's Disease: Islamic Viewpoint.Hassan Chamsi-Pasha & Mohammed Ali Albar - 2015 - American Journal of Bioethics Neuroscience 6 (1):67-69.
References found in this work
Beyond informed consent: the therapeutic misconception and trust.Inmaculada de Melo-Martin & A. Ho - 2008 - Journal of Medical Ethics 34 (3):202-205.
Therapeutic Misconception in Clinical Research: Frequency and Risk Factors.Paul S. Appelbaum, Charles W. Lidz & Thomas Grisso - 2004 - IRB: Ethics & Human Research 26 (2):1.
What should research participants understand to understand they are participants in research?David Wendler & Christine Grady - 2008 - Bioethics 22 (4):203–208.
Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease.Z. Master, M. McLeod & I. Mendez - 2007 - Journal of Medical Ethics 33 (3):169-173.
Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson's disease and proposed criteria for use of sham surgery controls.R. L. Albin - 2002 - Journal of Medical Ethics 28 (5):322-325.
